Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Garland Almquist"'
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 3, Iss , Pp 100060- (2021)
Patients with metastatic renal cell carcinoma are often affected by metastases to the brain that result in significant complications as well as limitations in clinical trial participation. Early generation tyrosine-kinase inhibitor and immune checkpo
Externí odkaz:
https://doaj.org/article/bc36cb51979749db81bd234cdd58fae3
Autor:
Kerri E. Andre, Robert Hood, Audrey Jane Gaskins, Jennifer F. Kawwass, Rebecca Garland Almquist, Michael R. Kramer, Heather S. Hipp
Publikováno v:
Fertility and Sterility. 118:e85
Autor:
Rachel Fried, R. Garland Almquist, Heather S. Hipp, Jennifer F. Kawwass, Sheree L. Boulet, Chloe M. Barrera
Publikováno v:
Reproductive biomedicine online. 44(6)
Research Question Is race/ethnicity or access to care, as defined by insurance coverage, distance to clinic, and zip code, associated with care discontinuation following in vitro fertilization (IVF)? Design A retrospective cohort study of 878 diverse
Autor:
Chandra Rao, Monika Anand, Elizabeth Bronson, Kathryn E. Ware, Anika Agarwal, Daniella Runyambo, Andrew J. Armstrong, Jason A. Somarelli, Patrick Healy, Tian Zhang, Megan Ann McNamara, Daniel J. George, Rengasamy Boominathan, Taofik Oyekunle, R. Garland Almquist, Sally S.E. Park
Publikováno v:
Biomarker Research
Biomarker Research, Vol 9, Iss 1, Pp 1-12 (2021)
Biomarker Research, Vol 9, Iss 1, Pp 1-12 (2021)
BackgroundA subset of men with metastatic prostate cancer (mPC) responds to immune checkpoint inhibitors, and there is an unmet need to predict those most likely to benefit. We characterized circulating tumor cells (CTCs) for expression of immune che
Autor:
Tian Zhang, Cierra S. Hong, Daniel J. George, Kristen A. Batich, Garland Almquist, Luis Villa
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 3, Iss, Pp 100060-(2021)
Patients with metastatic renal cell carcinoma are often affected by metastases to the brain that result in significant complications as well as limitations in clinical trial participation. Early generation tyrosine-kinase inhibitor and immune checkpo
Autor:
Tian Zhang, Anika Agarwal, R. Garland Almquist, Daniella Runyambo, Sally Park, Elizabeth Bronson, Rengasamy Boominathan, Chandra Rao, Monika Anand, Taofik Oyekunle, Patrick Healy, Megan A. McNamara, Kathryn Ware, Jason A. Somarelli, Daniel J. George, Andrew J. Armstrong
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-12 (2021)
Abstract Background A subset of men with metastatic prostate cancer (mPC) responds to immune checkpoint inhibitors, and there is an unmet need to predict those most likely to benefit. We characterized circulating tumor cells (CTCs) for expression of
Externí odkaz:
https://doaj.org/article/73be55596a3a4b3aa52babf1cbd5b01d